Softacort 3 clinical trials

Prospective evaluation of the efficacy and safety of topical hydrocortisone treatment on clinical signs and symptoms of dry eye disease associated with moderate meibomian gland dysfunction

This study is looking at a hydrocortisone eye drop to see if it helps with dry eyes caused by a common condition called Meibomian Gland Dysfunction (MGD). Researchers want to check if it improves symptoms and is safe to use. It's a later-stage study focusing on how well it works in real-world use.